5:24 PM
 | 
Jun 24, 2014
 |  BC Extra  |  Company News

Bionomics licenses BNC375 to Merck

Bionomics Ltd. (ASX:BNO; OTCBB:BMICY) jumped A$0.10 (22%) to A$0.53 in Australia on Tuesday after granting Merck & Co. Inc. (NYSE:MRK) exclusive, worldwide development and commercialization rights to Bionomics' preclinical BNC375 program, which targets...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >